LEADER 02113nam  2200565   450 
001 9910813012803321
005 20230803021111.0
010   $a1-78084-261-9
010   $a1-78084-262-7
035   $a(CKB)2550000001101127
035   $a(EBL)1179626
035   $a(OCoLC)854971659
035   $a(SSID)ssj0001599964
035   $a(PQKBManifestationID)16306262
035   $a(PQKBTitleCode)TC0001599964
035   $a(PQKBWorkID)14892589
035   $a(PQKB)10114859
035   $a(MiAaPQ)EBC1179626
035   $a(Au-PeEL)EBL1179626
035   $a(EXLCZ)992550000001101127
100   $a20220517d2013      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAdvances in the management of psoriatic arthritis /$feditor, Douglas J. Veale
205   $a1st ed.
210  1$aLondon, England :$cFuture Medicine Ltd.,$d[2013]
210  4$dİ2013
215   $a1 online resource (99 p.)
300   $aDescription based upon print version of record.
311   $a1-78084-263-5 
327   $aTitle page; Copyright page; Contents; Foreword. Psoriatic arthritis: recognizing and managing disease in the 21st century; 1. Symptoms and diagnosis of psoriatic arthritis; 2. Classification and monitoring of disease activity; 3. Psoriatic arthritis pathogenesis; 4. Imaging features in psoriatic arthritis; 5. Treatment options: NSAIDs and DMARDs; 6. Treatment options: biologicals; 7. Prognosis and treatment guidelines; Index
330   $aAdvances in the management of psoriatic arthritis
606   $aPsoriatic arthritis
606   $aPsoriatic arthritis$xTreatment
606   $aPsoriatic arthritis$xChemotherapy
615  0$aPsoriatic arthritis.
615  0$aPsoriatic arthritis$xTreatment.
615  0$aPsoriatic arthritis$xChemotherapy.
676   $a616.7227
702   $aVeale$b Douglas J.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910813012803321
996   $aAdvances in the management of psoriatic arthritis$93955230
997   $aUNINA